Glial cell line-derived neurotrophic factor receptor-α1 expressed in striatum in trans regulates development and injury response of dopamine neurons of the substantia nigra. 2011

Nikolai Kholodilov, and Sang Ryong Kim, and Olga Yarygina, and Tatyana Kareva, and Jin Whan Cho, and Amy Baohan, and Robert E Burke
Department of Neurology, The College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

Many of the cellular effects of glial cell line-derived neurotrophic factor are initiated by binding to GNDF family receptor alpha-1 (GFRα1), and mediated by diverse intracellular signaling pathways, most notably through the Ret tyrosine kinase. Ret may be activated by the cell autonomous expression of GFRα1 ('in cis'), or by its non-cell autonomous presence ('in trans'), in either a soluble or immobilized state. GFRα1 is expressed in the striatum, a target of the dopaminergic projection of the substantia nigra. To determine whether post-synaptic expression of GFRα1 in striatum in trans has effects on the development or adult responses to injury of dopamine neurons, we have created transgenic mice in which GFRα1 expression is selectively increased in striatum and other forebrain targets of the dopaminergic projection. Post-synaptic GFRα1 has profound effects on the development of dopamine neurons, resulting in a 40% increase in their adult number. This morphologic effect was associated with an augmented motor response to amphetamine. In adult mice, post-synaptic GFRα1 expression did not affect neuron survival following neurotoxic lesion, but it did increase the preservation of striatal dopaminergic innervation. We conclude that post-synaptic striatal GFRα1 expression has important effects on the biology of dopamine neurons in vivo.

UI MeSH Term Description Entries
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras
D051097 Glial Cell Line-Derived Neurotrophic Factor Receptors A family of GLYCOSYLPHOSPHATIDYLINOSITOL-anchored cell surface receptors that are specific for GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTORS. They form a multi-component receptor complex with PROTO-ONCOGENE PROTEIN C-RET and regulate a variety of intracellular SIGNAL TRANSDUCTION PATHWAYS in conjunction with c-ret protein. GDNF Family Receptor 1,GDNF Family Receptor 2,GDNF Family Receptor 3,GDNF Family Receptor 4,GDNF Family Receptor Alpha 1,GDNF Family Receptor Alpha 2,GDNF Family Receptor Alpha 3,GDNF Family Receptor Alpha 4,GDNF Receptors,GFRA1 Receptor,GFRA2 Receptor,GFRA3 Receptor,GFRA4 Receptor,Glial Derived Neurotrophic Factor Receptor 1,Glial Derived Neurotrophic Factor Receptor 2,Glial Derived Neurotrophic Factor Receptor 3,Glial Derived Neurotrophic Factor Receptor 4,Glial Cell Line Derived Neurotrophic Factor Receptors

Related Publications

Nikolai Kholodilov, and Sang Ryong Kim, and Olga Yarygina, and Tatyana Kareva, and Jin Whan Cho, and Amy Baohan, and Robert E Burke
August 1998, Journal of neurochemistry,
Nikolai Kholodilov, and Sang Ryong Kim, and Olga Yarygina, and Tatyana Kareva, and Jin Whan Cho, and Amy Baohan, and Robert E Burke
June 2001, Journal of chemical neuroanatomy,
Nikolai Kholodilov, and Sang Ryong Kim, and Olga Yarygina, and Tatyana Kareva, and Jin Whan Cho, and Amy Baohan, and Robert E Burke
August 2004, Brain research. Molecular brain research,
Nikolai Kholodilov, and Sang Ryong Kim, and Olga Yarygina, and Tatyana Kareva, and Jin Whan Cho, and Amy Baohan, and Robert E Burke
March 2001, Neuroscience letters,
Nikolai Kholodilov, and Sang Ryong Kim, and Olga Yarygina, and Tatyana Kareva, and Jin Whan Cho, and Amy Baohan, and Robert E Burke
December 1999, Gene therapy,
Nikolai Kholodilov, and Sang Ryong Kim, and Olga Yarygina, and Tatyana Kareva, and Jin Whan Cho, and Amy Baohan, and Robert E Burke
December 1993, Experimental neurology,
Nikolai Kholodilov, and Sang Ryong Kim, and Olga Yarygina, and Tatyana Kareva, and Jin Whan Cho, and Amy Baohan, and Robert E Burke
July 1999, Journal of neurochemistry,
Nikolai Kholodilov, and Sang Ryong Kim, and Olga Yarygina, and Tatyana Kareva, and Jin Whan Cho, and Amy Baohan, and Robert E Burke
August 2009, Molecular and cellular neurosciences,
Nikolai Kholodilov, and Sang Ryong Kim, and Olga Yarygina, and Tatyana Kareva, and Jin Whan Cho, and Amy Baohan, and Robert E Burke
May 2004, Journal of neurochemistry,
Nikolai Kholodilov, and Sang Ryong Kim, and Olga Yarygina, and Tatyana Kareva, and Jin Whan Cho, and Amy Baohan, and Robert E Burke
November 2005, Experimental neurology,
Copied contents to your clipboard!